Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Alcon (SWX:ALC) has launched TOTAL30 Multifocal for Astigmatism, a monthly ...
Porter Ophthalmology announced the release of a comprehensive new patient education article, Toric vs Non-Toric Lenses for Refractive Lens Exchange, offering clear, research-based information about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results